Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
Completed · Phase 1
Conditions studied: HIV Infections
In brief
This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.
Key facts
- Study ID
- NCT00135434
- Run by
- Bristol-Myers Squibb
- People needed
- 25
- Starts
- 2004-09-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2011-04-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy volunteers
Where it is running
- Clinical Pharmacology Unit, Bristol-Myers Squibb Company — Hamilton, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.